Qian Y, Zhang J, Jiang C Y, Yuan C, Zhang Y, Liu J Y, Diao F Y, Ma X
Department of Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Zhonghua Fu Chan Ke Za Zhi. 2021 Dec 25;56(12):868-875. doi: 10.3760/cma.j.cn112141-20210831-00477.
To investigate the impact of body mass index (BMI) on clinical effect and fresh cycle embryo transfer pregnancy outcome of in vitro fertilization or intracytoplasmic sperm injection (IVF/ICSI) in patients with early follicular phase prolonged protocol. From January 1st, 2018 to July 1st, 2020, 2 257 cases of early follicular long-term protocol in IVF/ICSI and embryo transfer were collected using the clinical assisted reproductive technologies management system software database of the First Affiliated Hospital of Nanjing Medical University. Patients were divided into three groups according to the recommended Asian BMI cut-off points: low body mass group (BMI<18.5 kg/m), normal body mass group (18.5≤BMI<24.0 kg/m), and high body mass group (BMI≥24.0 kg/m). The ovarian stimulation characteristics among the groups were investigated. Then 1 741 fresh embryo transfer cycles were selected and divided into three groups as above, and then the ovulation induction and clinical outcomes were analyzed among the groups. There were significant differences in the starting dosage of gonadotrophin (Gn), total dosage of Gn and days of Gn used among the low body mass group, normal body mass group, and high body mass group in the 2 257 IVF/ICSI cycles (all <0.01). The high body mass group needed the most amount of Gn [(2 159±668) U] and longest Gn days [(12.3±2.5) days]. The estradiol and progesterone levels [(7 474±4 852) pmol/L, (3.4±1.9) nmol/L] on hCG trigger day in the high body mass group were lower than those in the low body mass group and normal body mass group (all <0.01). The oocytes retrieved in high body mass group (8.4±4.1) were significantly lower than normal body mass group (<0.05). The normal fertilization number, the available embryo number and high quality embryo number were all lower in the high body mass group than other two groups, while no significant difference showed (all >0.05). In 1 741 cycles of fresh embryo transfer, the average number of transplanted embryos in the low body mass group (1.2±0.4) was decreased compared with the other two groups (<0.05), while the biochemical pregnancy rate, clinical pregnancy rate and live birth rate in the normal body mass group were higher compared with the other two groups, but the differences showed no statistically significance (all >0.05). Increased BMI might affect ovulation induction response in early follicular phase prolonged protocol IVF/ICSI patients, leading to the increase of Gn dosage and the extension of Gn induction days. Although there is no significant difference in pregnancy outcome among different BMI groups, considering the increased risk of adverse perinatal outcomes during subsequent pregnancy in overweight or obese patients, certain attention should still be paid to the control of BMI in patients receiving assisted reproduction treatment with early follicular phase prolonged protocol.
探讨体质量指数(BMI)对卵泡期延长方案患者体外受精或卵胞浆内单精子注射(IVF/ICSI)临床效果及新鲜周期胚胎移植妊娠结局的影响。采用南京医科大学第一附属医院临床辅助生殖技术管理系统软件数据库,收集2018年1月1日至2020年7月1日期间2257例接受IVF/ICSI及胚胎移植的卵泡期长期方案患者。根据推荐的亚洲BMI切点将患者分为三组:低体质量组(BMI<18.5 kg/m²)、正常体质量组(18.5≤BMI<24.0 kg/m²)和高体质量组(BMI≥24.0 kg/m²)。研究各组间的卵巢刺激特征。然后选取1741个新鲜胚胎移植周期并按上述方法分为三组,分析各组间的促排卵情况及临床结局。在2257个IVF/ICSI周期中,低体质量组、正常体质量组和高体质量组在促性腺激素(Gn)起始剂量、Gn总剂量及Gn使用天数方面差异均有统计学意义(均<0.01)。高体质量组所需Gn量最多[(2159±668)U],Gn使用天数最长[(12.3±2.5)天]。高体质量组在人绒毛膜促性腺激素(hCG)扳机日的雌二醇和孕酮水平[(7474±4852)pmol/L,(3.4±1.9)nmol/L]低于低体质量组和正常体质量组(均<0.01)。高体质量组获卵数(8.4±4.1)明显低于正常体质量组(<0.05)。高体质量组正常受精数、可用胚胎数及优质胚胎数均低于其他两组,但差异无统计学意义(均>0.05)。在1741个新鲜胚胎移植周期中,低体质量组平均移植胚胎数(1.2±0.4)低于其他两组(<0.05),而正常体质量组的生化妊娠率、临床妊娠率及活产率高于其他两组,但差异无统计学意义(均>0.05)。BMI增加可能影响卵泡期延长方案IVF/ICSI患者的促排卵反应,导致Gn用量增加及Gn促排卵天数延长。尽管不同BMI组妊娠结局差异无统计学意义,但考虑到超重或肥胖患者后续妊娠期间围产期不良结局风险增加,对于接受卵泡期延长方案辅助生殖治疗的患者,仍应注意控制BMI。